Stereotaxis: Bringing robotics to cardiac ablation
Stereotaxis (NYSE:STXS) in September 2020 announced the installation in Helsinki, Finland, and Phoenix, Ariz., of the first Genesis Robotic Magnetic Navigation (RMN) systems to treat heart rhythm disorders.Robotic magnetic navigation provides robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias, according to St. Louis–based Stereotaxis.
“This technology allows us to positively address the increasing number of patients with complex arrhythmias. In addition, it provides us a competitive advantage to other Nordic centers concerning education and learning,” said Antti Vento, medical director of the Helsinki Heart and Lung Center.